Real-time enrollment status for this neuroendocrine tumors clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 6:09 AM UTC
| NCT Number | NCT06395402 |
| Recruiting Status | Recruiting |
| Condition | Neuroendocrine Tumors |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Iowa |
| Last Updated on CT.gov | July 22, 2025 (Jul 22, 2025) |
As of July 20, 2026: Clinical trial NCT06395402 is currently recruiting participants. This phase2 study for neuroendocrine tumors is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Iowa. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06395402 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06395402 was last updated Jul 22, 2025 (July 22, 2025). HelloStudys verifies this status automatically.